Phase 1 Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 30 and 85 years old (male or female)
- You have been officially diagnosed with Parkinson's disease using standard medical diagnostic guidelines
- You have had Parkinson's disease for more than 3 years
- Your Parkinson's symptoms are at a moderate or lower level of severity when your medication is working (confirm with trial site)
- Your Parkinson's symptoms improve significantly (by more than 30%) when you take levodopa medication
Who may not be able to join:
- You have a type of Parkinson's-like condition that is not standard Parkinson's disease, or your Parkinson's-like symptoms are caused by another condition
- You have another condition affecting your brain or nervous system
- You have another serious illness affecting your overall health or organ function
- You have a severe mental health condition
- You are currently taking hormone therapy or certain powerful drugs that affect the immune system, and you are unable to stop taking them during the trial
- You have memory or thinking difficulties (based on a standard cognitive test score below 24)
- You experience severe uncontrolled involuntary movements related to your Parkinson's medication (confirm with trial site)
- You have previously had brain surgery
- You regularly take blood-thinning medication long-term
- A brain scan has shown abnormalities that could interfere with surgery or the study's follow-up tests
- You are unable to have an MRI scan or a specific type of brain imaging scan called an AV133 PET scan
- You are pregnant or planning to become pregnant
- The trial doctors have determined for any other reason that participation would not be appropriate for you
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assessment of changes during the medication "off" time in Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS), part III, in comparison with baseline values.; Incidence and severity of transplant-related adverse events.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.